Medical Weight Loss for Kenner, Louisiana Residents
Kenner, Louisiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Kenner through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Kenner Residents Choose New Hope Weight Loss
Kenner patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Louisiana and beyond since 2020.
Kenner is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Kenner patients at home.
Patients across Kenner and the surrounding area connect with Dr. Sharma by secure video, wherever they live in Louisiana. We care for patients throughout the greater Kenner area and the New Orleans metro, with bilingual Spanish care. Whether you are starting your first GLP-1 program or switching from a brand medication, your Kenner treatment plan is built around your health history and goals.
Telehealth removes the distance between Kenner and specialized care: your consultation happens wherever you are in Louisiana. The first step is a $119 physician review; if you are not a candidate you are not charged, and compounded semaglutide starts at $166/month.
GLP-1 Weight Loss Programs Available
Compounded semaglutide, from $166/mo (90-day program $499)
The 90-day Metabolic Reset is our most-chosen plan. Semaglutide shares its active ingredient with Wegovy® and Ozempic®; in trials of the branded drug, patients lost an average of 15-17% of body weight under physician supervision.
Compounded tirzepatide, from $233/mo
Tirzepatide's dual GLP-1/GIP action reached up to 22.5% body-weight loss in trials of the branded medication, the advanced option for Kenner patients.
The physician review is a flat $119, with medication billed separately; HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Kenner
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Kenner address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Kenner
How do I get treatment from Kenner?
As a Kenner, Louisiana patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Kenner?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Kenner in cold-pack packaging, no lines and no drive.
How much does it cost for Kenner patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Kenner do you serve?
We serve patients from across Kenner by telehealth, including the greater Kenner area and the New Orleans metro, with bilingual Spanish care.
How soon can a Kenner patient start treatment?
Most Kenner patients complete the online intake in minutes and have Dr. Sharma's video review within about 48 hours. If you are a candidate and telehealth-eligible, medication ships shortly after, so many patients begin within roughly a week of starting.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Kenner, Louisiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.